-
-
Overview
-
Please contact us at for specific academic pricing.
Background
BAY-1895344 is a potent and selective ATM inhibitor with IC50 of 7 nM. BAY 1895344 shows strong anti-tumor efficacy in monotherapy and forms a strong combined potential with the targeted alpha therapy Radium-223 dichloride.BAY 1895344 has no activity in hERG patch-clamp assay. In the tumor model of DNA damage defects, BAY 1895344 single drug administration or combined treatment with other DNA damage-inducing therapies have good efficacy.
-
- Properties
-
Overview